Clinical Trial Update: Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating norfloxacin for patients with cirrhosis and severe liver failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Norfloxacin (Norfloxacin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cirrhosis | Phase 3 | Status: TERMINATED